GSK Epilepsy, Bipolar Drug Linked To Meningitis
The U.S. Food and Drug Administration is revising the label on GlaxoSmithKline PLC epilepsy and bipolar disorder drug Lamictal to warn consumers that it can cause viral meningitis, which can in...To view the full article, register now.
Already a subscriber? Click here to view full article